Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT02563860
Eligibility Criteria:
Inclusion Criteria:
* Females patients,
* Genetically confirmed RTT,
* Ambulatory.
Exclusion Criteria:
* Presence of co morbid non-Rett related disease,
* History of adverse reaction/hypersensitivity to statins,
* Levels of aspartate-amino trans-ferase (AST), alanine-amino transferase (ALT) or creatine kinase (CK) triple the normal values,
* Active liver disease,
* Concomitant use of strong CYP3A4 inhibitors,
* Condition predis-posing to renal failure secondary to rhabdomyolysis (scoliosis surgery within 6 months),
* Oral contraceptives use.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
3 Years
Study:
NCT02563860
Study Brief:
Protocol Section:
NCT02563860